trending Market Intelligence /marketintelligence/en/news-insights/trending/iI5DXbJnSBIbt5jfxhrwpg2 content esgSubNav
In This List

Creative Medical Technology files patent on stem cell stroke therapy

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Creative Medical Technology files patent on stem cell stroke therapy

Creative Medical Technology Holdings Inc. filed a patent on its stem cell stroke therapy.

The patent application covers Creative Medical's AmnioStem stem cell as a means to produce exosomes, nanoparticles which regenerate damaged brain tissue after a stroke, the company said in a news release. The AmnioStem stem cell is subject to issued U.S. patent #7,569,385 and was licensed from the University of California, San Diego.

Creative Medical is a clinical stage biotechnology company that engages in stem cell research and applications.